Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion
Open Access
- 1 July 2004
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 51 (1) , 55-67
- https://doi.org/10.1016/j.critrevonc.2004.02.001
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Breast cancer and hormone-replacement therapy: the Million Women StudyPublished by Elsevier ,2003
- The Essential Role of the Aromatase/P450aromSeminars in Reproductive Medicine, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Estrogen receptor beta in breast cancer.Endocrine-Related Cancer, 2002
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Estrogen receptor status of breast cancer: a marker of different stages of tumor or different entities of the disease?Medical Hypotheses, 1997
- ICI 182,780, a new antioestrogen with clinical potentialThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Risk Factors for Breast Cancer in Women with Proliferative Breast DiseaseNew England Journal of Medicine, 1985
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896